180 related articles for article (PubMed ID: 20634326)
1. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.
Kanaan N; Claes K; Devogelaer JP; Vanderschueren D; Depresseux G; Goffin E; Evenepoel P
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1887-92. PubMed ID: 20634326
[TBL] [Abstract][Full Text] [Related]
2. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
[TBL] [Abstract][Full Text] [Related]
3. Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.
Coskun Y; Paydas S; Balal M; Soyupak S; Kara E
Transplant Proc; 2016; 48(6):2040-5. PubMed ID: 27569941
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
[TBL] [Abstract][Full Text] [Related]
5. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
[TBL] [Abstract][Full Text] [Related]
6. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
[TBL] [Abstract][Full Text] [Related]
7. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
Han SY; Hwang EA; Park SB; Kim HC; Kim HT
Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
Kidney Int; 2019 Jun; 95(6):1461-1470. PubMed ID: 30922664
[TBL] [Abstract][Full Text] [Related]
9. Renal phosphate loss in long-term kidney transplantation.
Sirilak S; Chatsrisak K; Ingsathit A; Kantachuvesiri S; Sumethkul V; Stitchantrakul W; Radinahamed P; Disthabanchong S
Clin J Am Soc Nephrol; 2012 Feb; 7(2):323-31. PubMed ID: 22134626
[TBL] [Abstract][Full Text] [Related]
10. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
[TBL] [Abstract][Full Text] [Related]
12. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
Evenepoel P; Meijers BK; de Jonge H; Naesens M; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1829-36. PubMed ID: 18922992
[TBL] [Abstract][Full Text] [Related]
13. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients.
Huang WH; Yu MC; Huang JY; Lai PC
PLoS One; 2013; 8(5):e63263. PubMed ID: 23675468
[TBL] [Abstract][Full Text] [Related]
15. Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study.
Bubenicek P; Sotornik I; Vitko S; Teplan V
Kidney Blood Press Res; 2008; 31(3):196-202. PubMed ID: 18535393
[TBL] [Abstract][Full Text] [Related]
16. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
18. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
[TBL] [Abstract][Full Text] [Related]
19. Development of lumbar bone mineral density in the late course after kidney transplantation.
Brandenburg VM; Ketteler M; Fassbender WJ; Heussen N; Freuding T; Floege J; Ittel TH
Am J Kidney Dis; 2002 Nov; 40(5):1066-74. PubMed ID: 12407653
[TBL] [Abstract][Full Text] [Related]
20. Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels.
Trombetti A; Richert L; Hadaya K; Graf JD; Herrmann FR; Ferrari SL; Martin PY; Rizzoli R
Eur J Endocrinol; 2011 May; 164(5):839-47. PubMed ID: 21335460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
